RightFit
Not yet recruitingPhase 1 / Phase 2

Feasibility and Acceptability of Amani

Feasibilty and Acceptability of Amani, a Virtual Reality Application for Adults With Sickle Cell Disease

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years and older
Sex
All sexes
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

Not stated in the study description — ask the study team about visits and procedures.

Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study tests Amani, a virtual reality program for adults with sickle cell disease. The program aims to help people cope and connect with others who have the disease. The study will see if Amani is practical to use and acceptable to patients.

Adults with sickle cell disease (SCD) experience severe pain, emotional distress, and social isolation that diminish their quality of life. This project will test Amani, a novel virtual reality supportive care intervention designed to improve coping skills and strengthen peer support. If feasible and acceptable, Amani offers an accessible digital supportive care intervention to improve psychological well-being and quality of life among individuals living with SCD.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Are age 18 or older and have sickle cell disease.
  • Get most of your sickle cell care at the Massachusetts General Hospital (MGH) Sickle Cell Disease Center.
  • Can understand and speak English, since Amani is only available in English.

Who can't join

  • Have a severe mental health condition, such as a psychotic disorder (trouble knowing what is real) or bipolar disorder (major mood swings), or serious thinking or memory problems that your blood doctor believes would prevent you from taking part.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: * Adults (≥ 18 years) who are diagnosed with sickle cell disease * Primarily followed at the Massachusetts General Hospital (MGH) Sickle Cell Disease Center * Have ability to comprehend and speak English given Amani is currently only available in English. Exclusion Criteria: * Have severe psychiatric (psychotic disorder, bipolar disorder) or cognitive impairment which the treating hematologist believes would preclude ability to participate in the clinical trial

Study sites (1)

MA